Telemedical management in patients waiting for transcatheter aortic valve implantation: the ResKriVer-TAVI study design
Description
CONCLUSIONS: ResKriVer-TAVI will be the first randomized, controlled trial investigating a telemedical approach before TAVI in patients with AS. We hypothesize that primary and secondary endpoints of AS patients with TIM will be superior to standard
